These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17158338)

  • 1. Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy.
    Zhou CC; Ahmad S; Mi T; Xia L; Abbasi S; Hewett PW; Sun C; Ahmed A; Kellems RE; Xia Y
    Circ Res; 2007 Jan; 100(1):88-95. PubMed ID: 17158338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling.
    Zhou CC; Ahmad S; Mi T; Abbasi S; Xia L; Day MC; Ramin SM; Ahmed A; Kellems RE; Xia Y
    Hypertension; 2008 Apr; 51(4):1010-9. PubMed ID: 18259044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19.
    Espino-Y-Sosa S; Martinez-Portilla RJ; Torres-Torres J; Solis-Paredes JM; Estrada-Gutierrez G; Hernandez-Pacheco JA; Espejel-Nuñez A; Mateu-Rogell P; Juarez-Reyes A; Lopez-Ceh FE; Villafan-Bernal JR; Rojas-Zepeda L; Guzman-Guzman IP; Poon LC
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethylamine N-Oxide increases soluble fms-like tyrosine Kinase-1 in human placenta via NADPH oxidase dependent ROS accumulation.
    Chang QX; Chen X; Ming-Xin Yang ; Zang NL; Li LQ; Zhong N; Xia LX; Huang QT; Zhong M
    Placenta; 2021 Jan; 103():134-140. PubMed ID: 33120049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia.
    Onda K; Tong S; Nakahara A; Kondo M; Monchusho H; Hirano T; Kaitu'u-Lino T; Beard S; Binder N; Tuohey L; Brownfoot F; Hannan NJ
    Hypertension; 2015 Apr; 65(4):855-62. PubMed ID: 25667213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental growth factor blunts uterine artery responses to angiotensin II.
    Espinoza J; Betancourt A; Belfort MA; Shamshirsaz AA; Fox KA; Yallampalli C
    BJOG; 2019 Jul; 126(8):1058-1064. PubMed ID: 30771259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
    Zhao Y; Zheng YF; Luo QQ; Yan T; Liu XX; Han L; Zou L
    Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
    Ahmad S; Ahmed A
    Circ Res; 2004 Oct; 95(9):884-91. PubMed ID: 15472115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
    Takazawa Y; Maeshima Y; Kitayama H; Yamamoto Y; Kawachi H; Shimizu F; Matsui H; Sugiyama H; Yamasaki Y; Makino H
    Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor of activated T-cells (NFAT) regulates soluble fms-like tyrosine kinase-1 secretion (sFlt-1) from human placenta.
    Ye L; Gratton A; Hannan NJ; Cannon P; Deo M; Palmer KR; Tong S; Kaitu'u-Lino TJ; Brownfoot FC
    Placenta; 2016 Dec; 48():110-118. PubMed ID: 27871461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptoms.
    Tan L; Chen Z; Sun F; Zhou Z; Zhang B; Wang B; Chen J; Li M; Xiao T; Neuman RI; Niu J; Verdonk K; Lu X; Zhang JV; Danser AHJ; Yang Q; Fan X
    Clin Sci (Lond); 2022 Feb; 136(4):257-272. PubMed ID: 35103285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR (Epidermal Growth Factor Receptor) Signaling and the Mitochondria Regulate sFlt-1 (Soluble FMS-Like Tyrosine Kinase-1) Secretion.
    Hastie R; Brownfoot FC; Pritchard N; Hannan NJ; Cannon P; Nguyen V; Palmer K; Beard S; Tong S; Kaitu'u-Lino TJ
    Hypertension; 2019 Mar; 73(3):659-670. PubMed ID: 30636550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study.
    Anton L; Merrill DC; Neves LA; Gruver C; Moorefield C; Brosnihan KB
    Reprod Biol Endocrinol; 2010 Nov; 8():135. PubMed ID: 21050477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
    Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
    Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Angiotensin II type 1 receptor mediates the effects of low oxygen on early placental angiogenesis.
    Delforce SJ; Lumbers ER; Morosin SK; Wang Y; Pringle KG
    Placenta; 2019 Jan; 75():54-61. PubMed ID: 30712667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of aminopeptidase A expression during angiotensin II-induced choriocarcinoma cell proliferation through AT1 receptor involving protein kinase C- and mitogen-activated protein kinase-dependent signaling pathway.
    Ino K; Uehara C; Kikkawa F; Kajiyama H; Shibata K; Suzuki T; Khin EE; Ito M; Takeuchi M; Itakura A; Mizutani S
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3973-82. PubMed ID: 12915695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.